申请人:Merck & Co., Inc.
公开号:EP0157399A2
公开(公告)日:1985-10-09
Novel 4-(5H-dibenzo[a,d]cyclohepten-5-yl)-piperidine compounds of the formula:
are disclosed wherein the bond designation between the 10 and 11 positions indicates that the bond may be a saturated single bond or an unsaturated double bond,
X is hydrogen, halogen, trifluoromethyl or lower alkoxy;
R is, e.g., selected from the group consisting of:
a) a substituted aralkyl group represented by the formula:
wherein A is di(lower alkyl)amino or lower alkoxy;
b) an aralkenyl group represented by the formula:
where D is lower alkoxy;
c) a nitrogen containing alkyl group represented by the formula:
wherein Y is -CN,
or
d) an acyl group represented by the formula:
wherein R' is lower alkyl, substituted lower alkyl, phenyl or substituted phenyl, styryl or substituted styryl;
and acid addition salts thereof.
The compounds have the property of inhibiting calcium induced contraction of the smooth muscle.
式中的新型 4-(5H-二苯并[a,d]环庚烯-5-基)-哌啶化合物:
其中 10 和 11 位置之间的键表示该键可以是饱和单键或不饱和双键、
X 是氢、卤素、三氟甲基或低级烷氧基;
R是,例如,选自由下列组成的组
a) 取代的芳烷基,由式表示:
其中 A 是二(低级烷基)氨基或低级烷氧基;
b) 式中 D 代表低级烷氧基的芳烷基
其中 D 是低级烷氧基
c) 含氮烷基,由式表示:
其中 Y 为-CN、
或
d) 式中 R'为低级烷基、取代的低级烷基、苯基或取代的苯基的酰基:
其中 R'是低级烷基、取代的低级烷基、苯基或取代的苯基、苯乙烯基或取代的苯乙烯基;
及其酸加成盐。
这些化合物具有抑制钙诱导的平滑肌收缩的特性。